Gautam Siram, MD
Orthopaedic Surgery · Chevy Chase, MDNPI 1689820672
Payments from drug & device makers
Across 544 payments — averaging $621.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$175K
- Zimmer Biomet$161K
- Encore Medical, LP$492
- Stryker$482
- Microport Orthopedics Inc$357
- Medacta USA, Inc.$183
- plus $599 from 14 others
What the payments were for
- Consulting fees$242,47272%
- Speaking & faculty fees$36,89211%
- Travel & lodging$43,62513%
- Food & beverage$13,6494%
- Education$1,5130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 191 | $174,667 |
| Zimmer Biomet | 305 | $161,372 |
| Encore Medical, LP | 6 | $492 |
| Stryker | 9 | $482 |
| Microport Orthopedics Inc | 4 | $357 |
| Medacta USA, Inc. | 3 | $183 |
| Johnson & Johnson(2 entities) | 2 | $142 |
| Baudax Bio Inc. | 6 | $104 |
| Medtronic | 4 | $71 |
| Medical Device Business Services, Inc. | 3 | $49 |
| Pacira Pharmaceuticals Incorporated | 2 | $34 |
| Onkos Surgical, Inc. | 1 | $32 |
| Acumed LLC | 1 | $31 |
| Vertex | 1 | $25 |
| Ferring Pharmaceuticals Inc. | 1 | $24 |
| Bioventus LLC | 1 | $23 |
| Pacira Therapeutics, Inc. | 1 | $19 |
| Fidia Pharma USA Inc. | 1 | $18 |
| Misonix Inc | 1 | $15 |
| Davol Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$201,456
- REAL INTELLIGENCE$128,928
- Arcos$67,570
- Avenir$65,090
- G7$47,320
- Tandem$47,283
- REDAPT$39,993
- Taperloc$37,880
- POLARSTEM$28,163
- Legion$26,224
- RI.HIP NAVIGATION$24,075
- K-15 PORK$23,472
- OR3O Dual Mobility$21,037
- Legion Revision$19,287
- R3 ACETABULAR$16,469
- Anthology$10,801
- POLARCUP$8,128
- Journey II XR$7,889
- JOURNEY$4,460
- Hips Product Portfolio$4,375
How this compares
$338,151 in reported general payments places this provider in the 95th percentile of 378 orthopaedic surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 62 | $1,048 |
| Diclofenac Sodium ErDiclofenac Sodium | 27 | $662 |
| Meloxicam | 108 | $496 |
| Amoxicillin | 84 | $425 |
| Methylprednisolone | 24 | $236 |
| Tramadol Hcl | 36 | $107 |
| Pantoprazole Sodium | 15 | $102 |
| Oxycodone Hcl | 12 | $56 |
| Clindamycin Hcl | 11 | $55 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Chevy Chase
- Tushar PatelChevy Chase$295K
- Michael GoldsmithChevy Chase$70K
- Laura KeelingChevy Chase$31K
- Mark MyersonBaltimore$10.5M
- David DaluryTowson$8.1M
- Anand MurthiBaltimore$5.4M
- Timothy CoddTowson$3.7M
- Khaled KebaishBaltimore$3.5M
- Hamid HassanzadehBethesda$2M
- Michael AinLutherville$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.